Seeking Alpha

IMMU
Immunomedics, Inc. - NASDAQ

4/23/2014, 3:40 PM ET
Quote & Analysis Breaking News StockTalk
immu chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There is research on this stock available only to PRO subscribers.
Other Articles
IMMU vs. ETF Alternatives
Company Description

Immunomedics, Inc., is a biopharmaceutical company which is focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.